NEW YORK (GenomeWeb News) – Pathogenica today announced that it has signed a co-marketing pact with Life Technologies for sequencing-based diagnostic tests targeting hospital-acquired infections.

The exclusive deal covers Europe, the Middle East, and Africa and will combine Pathogenica's DxSeq technology with Life Tech's Ion Torrent PGM platform. The kits will be distributed for research use, the firms said, and are not for use in diagnosing hospital patients.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: omic analysis of permafrost microbes, hookworm genome, and more.

Biologists turn to environmental DNA sampling to determine whether elusive or invasive species are shedding DNA in a given area.

Rob Knight writes at Scientific American that microbiome studies are about to break out of the laboratory.

Harold Varmus, the director of the National Cancer Institute, has announced that he is stepping down after nearly five years.